Paul Skenes leads trader consensus at 41.5% implied probability for the 2026 NL Cy Young after a dominant early-season run with the Pirates, posting a 1.98 ERA, league-leading 0.64 WHIP, and 56 strikeouts over 50 innings in nine starts, building on his reigning award from last year. Shohei Ohtani ranks second at 25.1% following his seamless return to the Dodgers' rotation with a stellar 0.82 ERA across 44 innings, blending elite strikeout stuff with dual-threat value. Cristopher Sanchez's 10.5% share reflects his breakout 2.11 ERA and NL-leading 67 punchouts for the Phillies, while Yoshinobu Yamamoto (8.5%) and Chris Sale (6.5%) trail with respectable 3.60 and 2.20 ERAs but higher WHIPs and losses amid tougher matchups. No major injuries reported, with odds shifting on recent outings emphasizing innings durability and run prevention.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · ОновленоPaul Skenes 42%
Shohei Ohtani 26.5%
Cristopher Sanchez 11%
Yoshinobu Yamamoto 9%
$47,738 Обс.
$47,738 Обс.
Paul Skenes
42%
Shohei Ohtani
26%
Cristopher Sanchez
11%
Yoshinobu Yamamoto
9%
Chris Sale
7%
Jacob Misiorowski
6%
Nolan McLean
1%
Mason Miller
1%
Michael King
1%
Brandon Woodruff
1%
Freddy Peralta
1%
Mitch Keller
1%
Tyler Glasnow
1%
Nick Lodolo
<1%
Eury Perez
<1%
Hunter Greene
<1%
Logan Webb
<1%
Zack Wheeler
<1%
Spencer Strider
<1%
Jesus Luzardo
<1%
Nick Pivetta
<1%
Spencer Schwellenbach
<1%
Blake Snell
<1%
Paul Skenes 42%
Shohei Ohtani 26.5%
Cristopher Sanchez 11%
Yoshinobu Yamamoto 9%
$47,738 Обс.
$47,738 Обс.
Paul Skenes
42%
Shohei Ohtani
26%
Cristopher Sanchez
11%
Yoshinobu Yamamoto
9%
Chris Sale
7%
Jacob Misiorowski
6%
Nolan McLean
1%
Mason Miller
1%
Michael King
1%
Brandon Woodruff
1%
Freddy Peralta
1%
Mitch Keller
1%
Tyler Glasnow
1%
Nick Lodolo
<1%
Eury Perez
<1%
Hunter Greene
<1%
Logan Webb
<1%
Zack Wheeler
<1%
Spencer Strider
<1%
Jesus Luzardo
<1%
Nick Pivetta
<1%
Spencer Schwellenbach
<1%
Blake Snell
<1%
In the event of a tie, this market will resolve according to the official winner as determined by MLB rules. If multiple winners are announced then this market will resolve to the player whose listed last name comes first alphabetically.
If the 2026 MLB season is cancelled, postponed after December 31, 2026, 11:59 PM ET, or there is otherwise no winner declared within that timeframe, this market will resolve to “Other”.
The resolution source for this market will be official information from Major League Baseball; however, a consensus of credible reporting may also be used.
Ринок відкрито: Feb 18, 2026, 10:18 PM ET
Resolver
0x69c47De9D...In the event of a tie, this market will resolve according to the official winner as determined by MLB rules. If multiple winners are announced then this market will resolve to the player whose listed last name comes first alphabetically.
If the 2026 MLB season is cancelled, postponed after December 31, 2026, 11:59 PM ET, or there is otherwise no winner declared within that timeframe, this market will resolve to “Other”.
The resolution source for this market will be official information from Major League Baseball; however, a consensus of credible reporting may also be used.
Resolver
0x69c47De9D...Paul Skenes leads trader consensus at 41.5% implied probability for the 2026 NL Cy Young after a dominant early-season run with the Pirates, posting a 1.98 ERA, league-leading 0.64 WHIP, and 56 strikeouts over 50 innings in nine starts, building on his reigning award from last year. Shohei Ohtani ranks second at 25.1% following his seamless return to the Dodgers' rotation with a stellar 0.82 ERA across 44 innings, blending elite strikeout stuff with dual-threat value. Cristopher Sanchez's 10.5% share reflects his breakout 2.11 ERA and NL-leading 67 punchouts for the Phillies, while Yoshinobu Yamamoto (8.5%) and Chris Sale (6.5%) trail with respectable 3.60 and 2.20 ERAs but higher WHIPs and losses amid tougher matchups. No major injuries reported, with odds shifting on recent outings emphasizing innings durability and run prevention.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено
Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання